Rchr
J-GLOBAL ID：201401068836724943   Update date: Apr. 19, 2024

Iwasa Tsutomu

イワサ ツトム | Iwasa Tsutomu
Affiliation and department：
Kindai University Faculty of Medicine

About Kindai University Faculty of Medicine


Research field  (4)： Genomics ,  Tumor diagnostics and therapeutics ,  Tumor biology ,  Internal medicine - General
Papers (72)：
  • Hidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, Takashi Kurosaki, Yosuke Togashi, Kazuya Fukuoka, Megumi Goto, Yasutaka Chiba, Shuta Tomida, Takayo Ota, et al. Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade. Journal of Clinical Investigation. 2024. 134. 7
  • 尾崎 由記範, 岩朝 勤, 北野 滋久, 山下 万貴子, 鶴谷 純司, 高橋 將人, 向原 徹, 増田 慎三, 二村 学, 南 博信, et al. 治療前CD163はニボルマブ+化学療法における予後不良因子(WJOG9917BTR). 日本癌治療学会学術集会抄録集. 2023. 61回. O25-3
  • Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, Koji Matsumoto, Akihiko Shimomura, Mihoko Doi, Yasuo Miyoshi, Masato Takahashi, Yasuaki Sagara, Shinya Tokunaga, et al. Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B). Breast (Edinburgh, Scotland). 2023. 71. 22-28
  • Jun Masuda, Hitomi Sakai, Junji Tsurutani, Yuko Tanabe, Norikazu Masuda, Tsutomu Iwasa, Masato Takahashi, Manabu Futamura, Koji Matsumoto, Kenjiro Aogi, et al. Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial). Journal for ImmunoTherapy of Cancer. 2023. 11. 9. e007126-e007126
  • 尾崎 由記範, 鶴谷 純司, 向原 徹, 岩朝 勤, 高橋 將人, 田辺 裕子, 川端 英孝, 増田 慎三, 二村 学, 南 博信, et al. HER2陰性転移再発乳癌に対するニボルマブ+ベバシズマブ+パクリタキセル併用療法の第II相試験(WJOG9917B). 日本乳癌学会総会プログラム抄録集. 2023. 31回. 65-65
ｍore...
MISC (125)：
  • 村田修一, 谷崎潤子, 岩朝勤, 黒崎隆, 田中薫, 林秀敏, 中川和彦, 濱有一郎. ニボルマブ+イピリムマブ併用療法中に敗血症との鑑別を要する免疫関連下垂体炎を発症した肺腺癌の1例. 肺癌(Web). 2023. 63. 3
  • Jun Masuda, Junji Tsurutani, Norikazu Masuda, Yuko Tanabe, Tsutomu Iwasa, Masato Takahashi, Manabu Futamura, Koji Matsumoto, Kenjiro Aogi, Hiroji Iwata, et al. Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR+, HER2-metastatic breast cancer: WJOG11418B NEWFLAME trial. CANCER RESEARCH. 2021. 81. 4
  • Yukinori Ozaki, Shigehisa Kitano, Junji Tsurutani, Tsutomu Iwasa, Masato Takahashi, Toru Mukohara, Norikazu Masuda, Manabu Futamura, Hironobu Minami, Koji Matsumoto, et al. Immunological analysis of the combination therapy of nivolumab, paclitaxel and bevacizumab in patients with HER2negative MBC in NEWBEAT trial (WJOG9917BTR). CANCER RESEARCH. 2021. 81. 4
  • 武田真幸, 武田真幸, 中川和彦, 林秀敏, 岩朝勤, 川上尚人, 渡邉諭美, 山本昇, 米盛勧, 小山隆文, et al. ベンダムスチン塩酸塩経口剤(SyB C-0501)の進行性固形がん患者に対する第1相臨床試験. 日本癌治療学会学術集会(Web). 2021. 59th
  • 金村宙昌, 田中薫, 鈴木慎一郎, 黒崎隆, 磯本晃佑, 岩朝勤, 白石直樹, 林秀敏, 武田真幸, 中川和彦. 気管支鏡検査時の迅速細胞診(ROSE)の成功に関連する因子の検討. 気管支学. 2021. 43
ｍore...
Lectures and oral presentations  (12)：
  • Retrospective study of chemotherapy for elderly patients for breast cancer
    (2018 Japanese Society of Medical Oncology Annual Meeting 2018)
  • Phase II trial of Eribulin and S-1 combination therapy for advanced or recurrent breast cancer
    (ESMO ASIA 2017 2017)
  • Retrospective analysis of 74 breast cancer patients with Eribulin treatment
    (2017 Japanese Society of Medical Oncology Annual Meetinng 2017)
  • Phase I trial of Eribulin in combination with S-1 for advanced or recurrent breast cancer
    (San Antonio Breast Cancer Symposium 2014 2014)
  • 肺癌細胞株におけるIGF-1R 阻害剤 CP-751,871の放射線増感効果の検討
    (第68回日本癌学会学術総会 2009)
ｍore...
Education (2)：
  • 2005 - 2008 Kindai University, Faculty of Medicine Graduate school of Medical science, Department of Medical Oncology
  • 1997 - 2003 Kindai University, Faculty of Medicine
Professional career (1)：
  • MD. Ph.D (Kindai University)
Work history (6)：
  • 2014/04 - 現在 Kindai University, Faculty of Medicine Department of Medical Oncology Lucture
  • 2012/09 - 2014/03 Kindai University, Faculty of Medicine Department of Medical Oncology Assistant professor
  • 2010/07 - 2012/08 Dana-Farber Cancer Institute
  • 2010/05 - 2010/06 Kindai University, Faculty of Medicine Department of Medical Oncology Assistant professor
  • 2009/04 - 2010/04 National Hospital Organization Minami Wakayama Medical Center Department of respiratory medicine Staff
Show all
Committee career (2)：
  • 2022/07 - 現在 Japanese Breast Cancer Society Councilor
  • 2017/07 - 現在 日本臨床腫瘍学会 協議員
Association Membership(s) (4)：
THE JAPANESE RESPIRATORY SOCIETY ,  日本乳癌学会 ,  日本臨床腫瘍学会 ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM